Sherpa Healthcare Partners

Sherpa Healthcare Partners accounts for 18 tracked companies with verified cap-table data, 18 of which disclose round sizes totalling $2.1B. The median disclosed raise is $90M, and the largest is Hong Kong Asia Heart Centre at $400M, ahead of EpimAb Biotherapeutics ($219M) and ClinChoice Kunling ($212M).

The names that recur most often on these portfolio cap tables are Sherpa Healthcare Partners (18 companies), Lilly Asia Ventures (7 companies), Legend Capital (4 companies), IDG Capital (3 companies), Cormorant Asset Management (2 companies), Hony Capital (2 companies). By latest disclosed round, the market skews Series B (6), Series A (6), Series D (2), Series E (2).

• Companies tracked: 18
• Disclosed funding total: $2.1B across 18 companies
• Median disclosed raise: $90M
• Largest raise: Hong Kong Asia Heart Centre — $400M
• Stage mix: Series B 6 · Series A 6 · Series D 2 · Series E 2
• Most recent dated round: 2026-01-08

Best funded Sherpa Healthcare Partners companies

1. Hong Kong Asia Heart Centre — $400M (latest: Series D)
2. EpimAb Biotherapeutics — $219M (latest: Series C)
3. ClinChoice Kunling — $212M (latest: Series E)
4. ClinChoiceKunling — $212M (latest: Series E)
5. Visen Pharmaceuticals — $190M (latest: Series B)
6. Bota Biosciences — $145M (latest: Series B+)
7. EdiGene — $129M (latest: Series B)
8. Singleron Biotechnologies — $100M (latest: Series A)
9. Neukio Biotherapeutics — $90M (latest: Series A)
10. Spiro Medical — $67M (latest: Series A)
11. Starna Therapeutics — $66M (latest: Series B)
12. Alebund Pharmaceuticals — $60M (latest: Series B)
13. Appia Bio — $52M (latest: Series A)
14. Brise Pharma — $48M (latest: Series A)
15. Wuxi Biortus Biosciences — $46M (latest: Series B)

Sherpa Healthcare Partners — related firms and companies (56)

• Hong Kong Asia Heart Centre
• EpimAb Biotherapeutics
• ClinChoice Kunling
• ClinChoiceKunling
• Visen Pharmaceuticals
• Bota Biosciences
• EdiGene
• Singleron Biotechnologies
• Investors like Slow Ventures
• Wuxi Biortus Biosciences
• Investors like Salesforce Ventures
• Investors like Madrona
• Yingke Biopharmaceutical
• Investors like Bessemer Venture Partners
• Investors like Techstars Ventures
• PAQ Therapeutics
• Investors like Foundation Capital
• Investors like Lightbank
• Leadsynbio
• Investors like Betaworks
• Investors like Andreessen Horowitz
• Sherpa Healthcare Partners co-investors 2026
• Investors like F-Prime
• Investors like Gaingels
• Investors like Sherpa Healthcare Partners
• Investors like SoftBank Vision Fund
• Investors like Atlas Venture
• Companies backed by Sherpa Healthcare Partners
• Investors like BoxGroup
• Investors like DCM Ventures
• Investors like True Ventures
• Investors like Matrix
• Investors like QED Investors
• Investors like Meritech Capital Partners
• Investors like Lux Capital
• Investors like Sequoia Capital
• Investors like Digital Currency Group
• Investors like Motivate Venture Capital
• Investors like Norwest Venture Partners
• Investors like Amino Capital
• Investors like Ventioneers
• Firms like GV
• Investors like Balderton Capital
• Neukio Biotherapeutics
• Investors like Point72 Ventures
• Investors like Draper Associates
• Spiro Medical
• Investors like Ribbit Capital
• Investors like DCVC
• Starna Therapeutics
• Investors like Founders Fund
• Investors like Foundry Group
• Alebund Pharmaceuticals
• Investors like Correlation Ventures
• Investors like HSG
• Appia Bio

Sherpa Healthcare Partners alternatives · All research reports